PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $308,000 | -44.1% | 145,512 | -11.5% | 0.05% | -40.3% |
| Q3 2016 | $551,000 | +654.8% | 164,405 | +607.6% | 0.08% | +541.7% |
| Q2 2016 | $73,000 | +102.8% | 23,235 | +116.9% | 0.01% | +100.0% |
| Q1 2016 | $36,000 | -61.7% | 10,712 | -59.6% | 0.01% | -71.4% |
| Q4 2015 | $94,000 | -27.1% | 26,509 | +45.1% | 0.02% | -25.0% |
| Q1 2015 | $129,000 | +30.3% | 18,268 | +42.4% | 0.03% | +40.0% |
| Q4 2014 | $99,000 | – | 12,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |